ATYR
NASDAQ
$0.49
Atyr Pharma Inc (ATYR)
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company is headquartered in San Diego, California.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $2.86 (+487.38%)
Market Cap
$52M
P/B Ratio
0.81
FCF 5Y CAGR
+20.60%
Beta (5Y)
1.24
Price Chart
Valuation
Market Cap$52M
P/S275.73
P/B0.81
Profitability
Total Revenue (TTM)$190K
Gross Profit (TTM)-$56M
EBITDA-$73M
Operating Margin-38574%
EPS-$0.73
Growth & Risk
EPS 5Y CAGR-20.20%
Revenue 5Y CAGR-39.73%
FCF 5Y CAGR+20.60%
Beta (5Y)1.24
Sharpe Ratio-0.63